| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $78.0M | — | +42.0% |
| Cost of Revenue | $29.4M | — | +27.3% |
| Gross Profit | $48.7M | — | +52.6% |
| R&D Expense | $12.7M | — | +44.2% |
| SG&A Expense | $14.0M | — | +23.6% |
| Operating Income | -$4.8M | — | +43.1% |
| Pre-tax Income | -$3.0M | — | +68.6% |
| Income Tax | $0 | — | — |
| Net Income | -$3.0M | — | +68.6% |
| EPS (Basic) | -$0.05 | — | +95.7% |
| EPS (Diluted) | -$0.05 | — | +95.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $211.8M | -4.6% | — |
| Accounts Receivable | $40.0M | +15.6% | — |
| Inventory | $3.8M | -14.6% | — |
| Current Assets | $269.4M | -1.3% | — |
| Total Assets | $302.8M | -0.9% | — |
| Current Liabilities | $68.7M | -9.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.8M | — | +26.6% |
| Capital Expenditures | $78K | — | -75.2% |
| Investing Cash Flow | -$1.6M | — | -24.7% |
| Financing Cash Flow | $3.1M | — | +738.7% |
| Free Cash Flow | -$11.9M | — | +27.5% |
| Total Liabilities | $68.7M | -9.3% | — |
| Stockholders' Equity | $234.1M | +1.9% | +160.0% |